Healthcare AI governance
Validation, regulatory classification, audit trails, human oversight and hallucination controls are usually treated as five separate compliance exercises, run by different people, against different checklists. They are one governance problem. This guide covers how the pieces fit together, and where governance efforts most often fail — not within any single piece, but at the seams between them.
Not legal or regulatory advice — this is a starting point for internal discussion, not a substitute for qualified counsel and a specific regulator's current guidance. Current as of September 2026.
The five pieces
Validation — demonstrating the system performs as intended, within a defined boundary and error rate, against a stated intended use. GAMP 5's risk-based approach is the common reference point in GxP environments. See GxP validation for AI systems.
Classification — knowing which regulatory regime applies, and what it requires. In the EU this often means high-risk classification under the AI Act layered on top of MDR/IVDR; in the US it can mean building a credibility argument under FDA's context-of-use framework; jurisdictions like Singapore use sectoral, role-based guidelines instead of a risk-tier statute. See the EU AI Act and healthcare AI, the FDA's AI credibility framework and Singapore's AI in healthcare guidelines.
Audit trail — a complete, attributable, reconstructible record of every output: the request, model version, retrieved evidence, verification results, and the human decision. See audit trail requirements for AI systems.
Human oversight — a checkpoint placed where a decision becomes consequential, that actually shows the reviewer enough to disagree, rather than a policy statement satisfied by someone clicking approve. See human-in-the-loop AI in healthcare.
Hallucination control — layered, structural mitigation (grounding, independent verification, claim-level confidence) rather than a prompting instruction, since no current technique eliminates the failure mode outright. See AI hallucination mitigation in regulated settings.
What converges across regulators
The specific instruments differ sharply — GAMP 5 validation protocols, EU AI Act conformity assessment, FDA credibility packages, and Singapore's role-based guidelines each have their own vocabulary, their own document types, their own process. What sits underneath nearly all of them converges: a precisely documented intended use or context of use, evidence proportional to risk and consequence, transparency about limitations, meaningful human oversight, and records sufficient to reconstruct a decision after the fact. Build a system to satisfy the underlying expectations, and complying with any one specific regime becomes a documentation exercise rather than a redesign — which matters considerably to any organisation operating across more than one jurisdiction.
Where governance actually fails
Rarely within a single piece — most teams can produce a validation protocol, an audit log, and a human-review policy in isolation. The failures show up at the seams: a validated system whose audit trail doesn't tie a specific output to the model version that produced it, so the validation claim can't actually be checked against what shipped. A human checkpoint that exists in the process diagram but shows the reviewer a polished final answer with no retrieved evidence attached, so there's nothing concrete to disagree with. A hallucination-mitigation layer that runs, but whose results never make it into the audit record, so a verification check that caught an error leaves no trace that it happened. Each piece, built by a different team against a different checklist, tends to produce exactly these gaps. Built as one integrated system, they don't occur in the first place.
Design for this from the start
Retrofitting validation, audit trails and oversight onto a system already in production is expensive and often incomplete — the seams described above are exactly what gets missed. Designing for all five pieces from the first architecture decision costs comparatively little: a system that logs the model version alongside every output, retrieves from a governed corpus by default, and surfaces claim-level evidence to a reviewer isn't meaningfully harder to build than one that doesn't. It just has to be a deliberate choice made early, not a feature added after a review finds the gap.
Where Eclypse sits: every deployment is built against a documented intended use, grounded in a governed corpus, independently verified before human review, and logged as a single reconstructible record per output — the five pieces as one design, not five compliance projects.
Read next
- GxP validation for AI systems — GAMP 5's risk-based model applied to software that behaves probabilistically.
- The EU AI Act and healthcare AI — why most clinical AI lands high-risk, and what that requires beyond MDR.
- The FDA's AI credibility framework — context of use, model risk, and what counts as evidence.
- Audit trail requirements for AI systems — the six elements a complete record needs, and where the hole usually is.
- Human-in-the-loop AI in healthcare — designing the checkpoint, not just declaring one.
- AI hallucination mitigation in regulated settings — why prompting isn't a control, and the layered defence that is.
Common questions about healthcare AI governance.
What is healthcare AI governance?
The combined practices that make an AI system's use defensible: validation against intended use, correct regulatory classification, a complete audit trail, meaningful human oversight, and hallucination control. Each is necessary; none is sufficient alone.
Do the same governance practices work across different regulators?
The instruments differ, but the underlying expectations converge — documented intended use, risk-proportional evidence, transparency, human oversight, and reconstructible records. Build to the expectations, not the instrument.
Where do most healthcare AI governance efforts fail?
At the seams between the pieces — an audit trail that doesn't capture the model version, or a human checkpoint with nothing to meaningfully disagree with — rather than within any single piece.
Does governance slow down an AI deployment?
Retrofitting it does. Designing for validation, audit trail and oversight from the start costs comparatively little.
Who is accountable when a governed AI system produces a wrong output?
Accountability follows the underlying decision — the reviewer, the deploying institution and the developer each carry distinct responsibilities that don't transfer to the AI system.
Is this legal or regulatory advice?
No. It's a starting point for internal discussion — get qualified regulatory and legal advice for your specific system and jurisdiction.
Tell us which piece is missing — we'll show you how the deployment closes it.
Book a working session
ECLYPSE
AI
Our proprietary AI orchestration platform for healthcare: one engine, a registry of reusable task modules and domain agents, and a governed knowledge base — deployed inside your walls and run by your team.